Observational studyThe journal of headache and pain2021

Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.

Fabrizio Vernieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.